NCT02187094View on ClinicalTrials.gov

Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Gastroparesis
Interventions
DRUG

TC-6499

DRUG

Placebo

Trial Locations (8)

27612

Wake Research associates, LLC, Raleigh

36608

Horizon Research Group, Inc., Mobile

37211

Quality Medical Research, Nashville

37421

ClinSearch, LLC, Chattanooga

72211

Prefered Research Partners, Inc., Little Rock

84058

Aspen Clinical Research, LLC, Orem

91911

Profil Institute for Clinical Research, Inc., Chula Vista

93003

Ventura Clinical Trials, Ventura

All Listed Sponsors
lead

Targacept Inc.

INDUSTRY

NCT02187094 - Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis | Biotech Hunter | Biotech Hunter